Findings in the Area of Chronic Disease Reported from University of Michigan (Longitudinal Associations Between Vision Neuropsychiatric, Musculoskeletal, and Cardiometabolic Chronic Diseases): Disease Attributes – Chronic Disease

2022 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Current study results on Disease Attributes - Chronic Disease have been published. According to news reporting from Ann Arbor, Michigan, by NewsRx journalists, research stated, “To compare the incidence and hazard of neuropsychiatric, musculoskeletal, and cardiometabolic conditions among adults with and without vision impairment (VI). Retrospective cohort study.”

Financial supporters for this research include Michigan Center for Clinical and health Research, National Institutes of Health (NIH) - USA, Research to Prevent Blindness (RPB), NIH National Eye Institute (NEI).

The news correspondents obtained a quote from the research from the University of Michigan, “The sample comprised enrollees in a large private health insurance provider in the United States, including 24 657 adults aged >= 18 years with VI and age and sex-matched controls. The exposure variable, VI, was based on low vision and blindness International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification (ICD-9-CM and ICD-10-CM), diagnosis codes. Physician-diagnosed incident neuropsychiatric, musculoskeletal, and cardiometabolic diseases were identified using ICD codes. Separate Cox proportional hazards regression models were used to assess the association of VI with incidence of 30 chronic conditions, adjusting for Elixhauser Comorbidity Index. Analyses were stratified by age 18-64 years and > 65 years. In individuals with VI aged 18-64 years (n = 7478), the adjusted hazard of neuropsychiatric (HR 2.1, 95% CI 1.9, 2.4), musculoskeletal (HR 1.8, 95% CI 1.7, 2.0), and cardiometabolic (HR 1.8, 95% CI 1.7, 2.0) diseases was significantly greater than in matched controls 5.5 Similar associations were seen between patients with VI aged > 65 years (n = 17 179) for neuropsychiatric (HR 2.4, 95% CI 2.1, 2.7), musculoskeletal (HR 1.8, 95% CI 1.6, 1.9), and cardiometabolic (HR 1.7, 95% CI 1.4, 2.0) diseases. VI was associated with a higher hazard of each of the 30 conditions we assessed, with similar results in both age cohorts.”

According to the news reporters, the research concluded: “Across the life span, adults with VI had an approximately 2-fold greater adjusted hazard for common neuropsychiatric, musculoskeletal, and cardiometabolic disorders compared with matched controls without VI.”

This research has been peer-reviewed.

For more information on this research see: Longitudinal Associations Between Vision Neuropsychiatric, Musculoskeletal, and Cardiometabolic Chronic Diseases. American Journal of Ophthalmology, 2022;235:163-171. American Journal of Ophthalmology can be contacted at: Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA. (Elsevier - www.elsevier.com; American Journal of Ophthalmology - http://www.journals.elsevier.com/american-journal-of-ophthalmology/)

Our news journalists report that additional information may be obtained by contacting Joshua R. Ehrlich, University of Michigan, Institute for Healthcare Policy and Innovation, Ann Arbor, MI, United States. Additional authors for this research include A. J. A. Y. Kolli, K. R. I. S. T. I. A. N. Seiler, N. E. I. L. Kamdar, Lindsey B. de Lott, Mark D. Peterson and Michelle A. Meade.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.ajo.2021.09.004. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)